Session Overview

The development of improved, innovative models for the detection of toxicity of drugs, chemicals, or chemicals in cosmetics is crucial to efficiently bring new products safely to market in a cost-effective and timely manner. In addition, improvement in models to detect toxicity may reduce the incidence of unexpected post-marketing toxicity and reduce or eliminate the need for animal testing.This session welcomes speakers looking to address this need with their research

Session Chair: Dr Phil Jeffrey

Honorary Professor

William Harvey Research Institute, Queen Mary University of London

VIEW PROFILE

KEYNOTE SPEAKER: DR GIANNI DAL NEGRO

HEAD OF COMPLEX IN VITRO SYSTEMS
GSK

Presentation Title: Industry translational thinking in the qualification of new complex in vitro models

Keynote Speaker: Dr Lorna Ewart

Head of Microphysiological Systems Centre of Excellence, Innovative Medicines at AstraZeneca

VIEW PROFILE

 

KEYNOTE SPEAKER: PROFESSOR MIKE PHILPOTT

Advances in Cell and Tissue Culture - Mike Philpott

PROFESSOR OF CUTANEOUS BIOLOGY
QUEEN MARY UNIVERSITY LONDON

The Presenters

 

Dr Parveen Sharma

Principal Investigator

University of Liverpool

Presentation Title: In vitro liver zonation of primary rat hepatocytes

Jonathan Temple

 

PhD STUDENT

University of Liverpool

Presentation Title: Imaging of 3D cell culture: challenges and opportunities

Dr Carl Sheridan

Senior Lecturer in Ocular Cell Transplantation

University of Liverpool

Presentation Title: Human Organ Culture anterior segment HOCAS the ex vivo eye model

 

Dr William R Critchley

Research Fellow

University of Leeds

I am interested in the post-translational modification of vascular endothelial growth factor receptor 2 and how this regulates angiogenesis. I am investigating the attachment of ubiquitin and ubiquitin-related modifiers to the receptor and internalisation components in endothelial cells.

Call for Papers





 

REGISTER NOW